Klinikum Mannheim Klinik fuer Dermatologie, Venerologie und Allergologie
Mannheim, Germany
Dermatologist in Mannheim, Baden-Württemberg
Klinik für Dermatologie, Venerologie und Allergologie, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim
About Klinikum Mannheim Klinik fuer Dermatologie, Venerologie und Allergologie
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Klinikum Mannheim Klinik fuer Dermatologie, Venerologie und Allergologie
During the past decade, Klinikum Mannheim Klinik fuer Dermatologie, Venerologie und Allergologie conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Vemurafenib in Participants With Metastatic Melanoma
2011-03-01
2016-02-24
Completed
3,219
STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
2011-07-01
2017-06-14
Completed
1,232
An Observational Safety Study in Zelboraf (Vemurafenib)-Treated Patients With BRAF-V600 Mutation-Positive Unresectable or Metastatic Melanoma (ZeSS)
2013-03-23
2016-07-26
Completed
339
An Analysis of Treatment Patterns and Outcomes for Basal Cell Carcinoma (BCC) Cancer Participants
2005-01-01
2011-12-31
Completed
134
Adjuvant Therapy of Completely Resected Merkel Cell Carcinoma With Immune Checkpoint Blocking Antibodies vs Observation
2014-06-01
2024-08-31
Active, not recruiting
180
Immuno-monitoring of Patients With Metastatic Melanoma (AJCC Stadium IV) Under Chemotherapy
2014-11-01
2016-12-31
Completed
12
Evaluation of the Safety and Tolerability of i.v. Administration of a Cancer Vaccine in Patients With Advanced Melanoma
2015-03-01
2023-05-01
Active, not recruiting
119
A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma
2017-12-11
2021-02-19
Terminated
446
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Klinikum Mannheim Klinik fuer Dermatologie, Venerologie und Allergologie" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "BioNTech SE" with 1 trials
sponsored, "Genentech, Inc." with 1 trials sponsored, "Genmab" with 1 trials sponsored and "IO Biotech"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Mannheim Klinik fuer Dermatologie, Venerologie und Allergologie"
#1 collaborator was "BioNTech SE" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Klinikum Mannheim Klinik fuer Dermatologie, Venerologie und Allergologie
According to Clinical.Site data, the most researched conditions in "Klinikum Mannheim Klinik fuer Dermatologie, Venerologie und Allergologie" are
"Basal Cell Carcinoma" (2 trials), "Malignant Melanoma" (2 trials), "Melanoma" (2 trials), "Advanced BRAFV600 Wild-type Melanoma" (1 trials) and "Advanced Melanoma" (1 trials). Many other conditions were trialed in "Klinikum Mannheim Klinik fuer Dermatologie, Venerologie und Allergologie" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum Mannheim Klinik fuer Dermatologie, Venerologie und Allergologie
Most popular intervention types in "Klinikum Mannheim Klinik fuer Dermatologie, Venerologie und Allergologie" are "Drug" (8 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Pembrolizumab" (4 trials), "Nivolumab" (2 trials), "5-FU" (1 trials), "Atezolizumab" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum Mannheim Klinik fuer Dermatologie, Venerologie und Allergologie
The vast majority of trials in "Klinikum Mannheim Klinik fuer Dermatologie, Venerologie und Allergologie" are
12 trials for "All" genders.
Clinical Trials Status at Klinikum Mannheim Klinik fuer Dermatologie, Venerologie und Allergologie
Currently, there are NaN active trials in "Klinikum Mannheim Klinik fuer Dermatologie, Venerologie und Allergologie".
undefined are not yet recruiting,
2 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Klinikum Mannheim Klinik fuer Dermatologie, Venerologie und Allergologie,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Mannheim Klinik fuer Dermatologie, Venerologie und Allergologie, 2 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".